Entry |
|
Name |
HPV E5 to p21-cell cycle G1/S
|
Definition |
E5 -| (CDKN1A,CDKN1B) |
Expanded |
K21812 -| (1026,1027) |
Class |
|
Type |
Pathogen
|
Pathway |
|
Disease |
|
Gene |
1026 | CDKN1A; cyclin dependent kinase inhibitor 1A |
1027 | CDKN1B; cyclin dependent kinase inhibitor 1B |
|
Perturbant |
K21812 (E5) | E5; HPV protein E5 |
|
Reference |
|
Authors |
de Freitas AC, Coimbra EC, Leitao Mda C |
Title |
Molecular targets of HPV oncoproteins: potential biomarkers for cervical carcinogenesis. |
Journal |
|
Reference |
|
Authors |
Venuti A, Paolini F, Nasir L, Corteggio A, Roperto S, Campo MS, Borzacchiello G |
Title |
Papillomavirus E5: the smallest oncoprotein with many functions. |
Journal |
|
Reference |
|
Authors |
DiMaio D, Petti LM |
Title |
The E5 proteins. |
Journal |
|
Reference |
|
Authors |
Tsao YP, Li LY, Tsai TC, Chen SL |
Title |
Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes. |
Journal |
|
LinkDB |
|